Latest Comments
-
skin cancer on Verisante Readies Aura Launch For Skin Cancer II have a scar on my right cheek from a large m...
-
pslice84 on Taking programmed cell death 180 degrees Nice article.For those interested in CBLI, this...
-
tommy456 on CEL-SCI on cusp of cancer game-changer I have owned this stock for almost 20 years. Th...
Most Commented
- CEL-SCI on cusp of cancer game-changer (1 Comment)
- Taking programmed cell death 180 degrees (1 Comment)
- Verisante Readies Aura Launch For Skin Cancer (1 Comment)
Posts by Themes
Abbott,
antioxidant,
Bayer,
Big Data,
Big Pharma,
cancer,
Cel-Sci,
Civanex,
CV,
Dolorac,
Dr. Joel Berstein,
Geert Kersten,
glucose monitoring,
HDL,
head and neck cancer,
InDanio,
InSite Vision,
ISRG,
J J,
JAMA,
KCI,
krill oil,
LDL,
LifePoint,
long-ideas,
MacuCLEAR,
Maquet,
Mark Pykett,
Mazor Robotics,
MC-1101,
MDXH,
Multikine,
needle-free,
Neoprobe,
Novartis,
oncology,
OnPoint Medical,
Parkash Gowd,
PPARy,
RepliCel,
Roche,
Rodman Renshaw,
Russell Ellison,
Sanofi-Aventis,
Silenor,
sleep aid,
Vaxil ,
Ventrus,
Winston Pharmaceuticals
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.












Full Index of Posts 34 posts, page 1 of 1
MDxHealth Strengthens Position In Epigenetics Testing
Vaxil Trial Validates Vaccine Technology
OnPoint's Big-Data Equals Big Opportunity
International Stem Cell Scores Neuronal Goal In Treating Parkinson's
DURECT Awaiting Pfizer Meeting With FDA On Remoxy
Immune-EpiCept To Get Multiple Clinical Shots On Goal
Trimel In Pre-NDA Meeting With FDA Next Month
In Conversation With InDanio Bioscience
Allon On Target For Pivotal PSP Data By Year End
Orgenesis Readies Novel Attack To Eradicate Diabetes
NovaBay's NeutroPhase Cleans Up Flesh-eating Disease
Cardium's Diamonds In The Rough Strategy
Verisante Readies Aura Launch For Skin Cancer
Neovasc Heart Pipeline In All The Right Places
Hadasit Bio Taps Hotbed Of Innovation At Israel Hospital
NASDAQ Approves Novadaq Listing
SQI Diagnostics Nears Big Diagnostic Contract
SafeStitch To Introduce AMID Stapler In Q2 2012
Nordion seeks to expand targeted therapies portfolio
RepliCel’s cell-based solution to hair loss
Winston Pharma gearing up for pivotal trials
Novadaq SPY deliveries to triple in second quarter
E. coli outbreak gives Thallion boost in visibility
Echo’s needle-free technology a game-changer
OncoVista gives personalized medicine a twist
InSite Vision awaiting SPA decision from FDA
In conversation with Simon Chin
2011 could be transition year for CytoSorbents
MacuCLEAR seeking financing for pivotal dry AMD trial
Taking programmed cell death 180 degrees
JAMA lymph node study heightens visibility of Neoprobe
OTC quotation leaves many dazed and confused
Ventrus ready to rub out hemorrhoids
CEL-SCI on cusp of cancer game-changer